Literature DB >> 17092522

A multi-compartment cell repopulation model allowing for inter-compartmental migration following radiation exposure, applied to leukaemia.

Mark P Little1.   

Abstract

There is much uncertainty about cancer risks at the high radiation doses used in radiotherapy (RT). It has generally been assumed that cancer induction decreases rapidly at high doses due to cell killing. However, this is not seen in all RT groups, and a model recently developed by Sachs and Brenner [2005. Solid tumor risks after high doses of ionizing radiation. Proc. Natl Acad. Sci. USA 102, 13040-13045] proposed a mechanism for repopulation of cells after radiation exposure that explained why this might happen, at least for solid tumours. In this paper, this model is generalized to allow for heterogeneity in the dose received, and various alternate patterns of repopulation are also considered. The model is fitted to the Japanese atomic bomb survivor leukaemia incidence data, and data for various therapeutically irradiated groups. Two sets of parameters from these model fits are used to assess the sensitivity of model predictions. It is shown that in general allowing for heterogeneity in dose distribution and haematopoietic stem cell migration results in lower risks than the same average dose administered uniformly and without such migration, although this does not hold in the limiting case of complete stem cell repopulation between radiation dose fractions. We also investigate the difference made by assuming a compartmental repopulation signal, and a global repopulation signal. In general we show that in the absence of stochastic extinction, compartmental repopulation always predicts a larger number of mutated cells than global repopulation. However, in certain dose regimes stochastic extinction cannot be ignored, and in these cases the numbers of mutated cells predicted with global repopulation can exceed that for compartmental repopulation. In general, mutant cell numbers are highly overdispersed, with variance much greater than the mean.

Entities:  

Mesh:

Year:  2006        PMID: 17092522     DOI: 10.1016/j.jtbi.2006.09.026

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  8 in total

1.  A new view of radiation-induced cancer.

Authors:  I Shuryak; R K Sachs; D J Brenner
Journal:  Radiat Prot Dosimetry       Date:  2010-11-27       Impact factor: 0.972

2.  A radiobiological model of radiotherapy response and its correlation with prognostic imaging variables.

Authors:  Mireia Crispin-Ortuzar; Jeho Jeong; Andrew N Fontanella; Joseph O Deasy
Journal:  Phys Med Biol       Date:  2017-01-31       Impact factor: 3.609

3.  A reanalysis of curvature in the dose response for cancer and modifications by age at exposure following radiation therapy for benign disease.

Authors:  Mark P Little; Marilyn Stovall; Susan A Smith; Ruth A Kleinerman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-06-09       Impact factor: 7.038

4.  Second cancers after fractionated radiotherapy: stochastic population dynamics effects.

Authors:  Rainer K Sachs; Igor Shuryak; David Brenner; Hatim Fakir; Lynn Hlatky; Philip Hahnfeldt
Journal:  J Theor Biol       Date:  2007-08-12       Impact factor: 2.691

5.  A new view of radiation-induced cancer: integrating short- and long-term processes. Part I: approach.

Authors:  Igor Shuryak; Philip Hahnfeldt; Lynn Hlatky; Rainer K Sachs; David J Brenner
Journal:  Radiat Environ Biophys       Date:  2009-06-18       Impact factor: 1.925

Review 6.  Second solid cancers after radiation therapy: a systematic review of the epidemiologic studies of the radiation dose-response relationship.

Authors:  Amy Berrington de Gonzalez; Ethel Gilbert; Rochelle Curtis; Peter Inskip; Ruth Kleinerman; Lindsay Morton; Preetha Rajaraman; Mark P Little
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-10-24       Impact factor: 7.038

Review 7.  Stem cell applications in military medicine.

Authors:  Gregory T Christopherson; Leon J Nesti
Journal:  Stem Cell Res Ther       Date:  2011-10-19       Impact factor: 6.832

Review 8.  Minimizing second cancer risk following radiotherapy: current perspectives.

Authors:  John Ng; Igor Shuryak
Journal:  Cancer Manag Res       Date:  2014-12-17       Impact factor: 3.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.